Cargando…

Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

OBJECTIVES: This study aimed to determine the in vitro susceptibility of commonly encountered Gram-negative bacilli (GNB) recovered from patients admitted to intensive care units (ICUs) in Taiwan against colistin, carbapenems, and other comparative agents. METHODS: In total, 758 nonduplicate GNB iso...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Chih-Cheng, Chen, Ying-Sheng, Lee, Nan-Yao, Tang, Hung-Jen, Lee, Susan Shin-Jung, Lin, Chin-Fu, Lu, Po-Liang, Wu, Jiunn-Jong, Ko, Wen-Chien, Lee, Wen-Sen, Hsueh, Po-Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421902/
https://www.ncbi.nlm.nih.gov/pubmed/30936726
http://dx.doi.org/10.2147/IDR.S194482
_version_ 1783404317509681152
author Lai, Chih-Cheng
Chen, Ying-Sheng
Lee, Nan-Yao
Tang, Hung-Jen
Lee, Susan Shin-Jung
Lin, Chin-Fu
Lu, Po-Liang
Wu, Jiunn-Jong
Ko, Wen-Chien
Lee, Wen-Sen
Hsueh, Po-Ren
author_facet Lai, Chih-Cheng
Chen, Ying-Sheng
Lee, Nan-Yao
Tang, Hung-Jen
Lee, Susan Shin-Jung
Lin, Chin-Fu
Lu, Po-Liang
Wu, Jiunn-Jong
Ko, Wen-Chien
Lee, Wen-Sen
Hsueh, Po-Ren
author_sort Lai, Chih-Cheng
collection PubMed
description OBJECTIVES: This study aimed to determine the in vitro susceptibility of commonly encountered Gram-negative bacilli (GNB) recovered from patients admitted to intensive care units (ICUs) in Taiwan against colistin, carbapenems, and other comparative agents. METHODS: In total, 758 nonduplicate GNB isolates were obtained from clinical specimens of ICU patients at seven medical centers in 2016. Minimum inhibitory concentrations (MICs) were determined using the Vitek 2 susceptibility system. The reference broth-microdilution method was performed to determine MICs of colistin. Five main carbapenemase genes among carbapenem-non-susceptible GNB and mcr-1–mcr5 genes among colistin non-wild-type or -resistant isolates were determined. RESULTS: After exclusion 38 Proteus mirabilis and 13 Morganella morganii spp. among 361 Enterobacteriaceae isolates, 34 (9.4%) isolates were carbapenem-insusceptible, 91.1% (n=31) were colistin wild type, and three and one Klebsiella pneumoniae isolates carried bla(KPC) and bla(OXA48)-like, respectively. Carbapenem-insusceptible isolates were found in 23.4% (30 of 128) and 63.0% (87 of 138) of isolates of the Pseudomonas aeruginosa and Acinetobacter baumannii complex, respectively. mcr-1 was detected in two (1.8%) Enterobacter cloacae isolates. Very major errors between two methods of susceptibility to colistin were found in 1.5% of K. pneumoniae, 27.5% of E. cloacae, 4.7% of P. aeruginosa, and 10.1% of A. baumannii complex isolates. CONCLUSION: In this study, 8.7% of Enterobacteriaceae isolates from ICUs were not susceptible to carbapenem, and bla(KPC) and bla(OXA48)-like were found among three and one carbapenem-insusceptible K. pneumoniae isolates, respectively. Colistin MICs determined by Vitek 2 were not reliable, especially for E. cloacae and A. baumannii complex isolates.
format Online
Article
Text
id pubmed-6421902
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-64219022019-04-01 Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) Lai, Chih-Cheng Chen, Ying-Sheng Lee, Nan-Yao Tang, Hung-Jen Lee, Susan Shin-Jung Lin, Chin-Fu Lu, Po-Liang Wu, Jiunn-Jong Ko, Wen-Chien Lee, Wen-Sen Hsueh, Po-Ren Infect Drug Resist Clinical Trial Report OBJECTIVES: This study aimed to determine the in vitro susceptibility of commonly encountered Gram-negative bacilli (GNB) recovered from patients admitted to intensive care units (ICUs) in Taiwan against colistin, carbapenems, and other comparative agents. METHODS: In total, 758 nonduplicate GNB isolates were obtained from clinical specimens of ICU patients at seven medical centers in 2016. Minimum inhibitory concentrations (MICs) were determined using the Vitek 2 susceptibility system. The reference broth-microdilution method was performed to determine MICs of colistin. Five main carbapenemase genes among carbapenem-non-susceptible GNB and mcr-1–mcr5 genes among colistin non-wild-type or -resistant isolates were determined. RESULTS: After exclusion 38 Proteus mirabilis and 13 Morganella morganii spp. among 361 Enterobacteriaceae isolates, 34 (9.4%) isolates were carbapenem-insusceptible, 91.1% (n=31) were colistin wild type, and three and one Klebsiella pneumoniae isolates carried bla(KPC) and bla(OXA48)-like, respectively. Carbapenem-insusceptible isolates were found in 23.4% (30 of 128) and 63.0% (87 of 138) of isolates of the Pseudomonas aeruginosa and Acinetobacter baumannii complex, respectively. mcr-1 was detected in two (1.8%) Enterobacter cloacae isolates. Very major errors between two methods of susceptibility to colistin were found in 1.5% of K. pneumoniae, 27.5% of E. cloacae, 4.7% of P. aeruginosa, and 10.1% of A. baumannii complex isolates. CONCLUSION: In this study, 8.7% of Enterobacteriaceae isolates from ICUs were not susceptible to carbapenem, and bla(KPC) and bla(OXA48)-like were found among three and one carbapenem-insusceptible K. pneumoniae isolates, respectively. Colistin MICs determined by Vitek 2 were not reliable, especially for E. cloacae and A. baumannii complex isolates. Dove Medical Press 2019-03-14 /pmc/articles/PMC6421902/ /pubmed/30936726 http://dx.doi.org/10.2147/IDR.S194482 Text en © 2019 Lai et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Clinical Trial Report
Lai, Chih-Cheng
Chen, Ying-Sheng
Lee, Nan-Yao
Tang, Hung-Jen
Lee, Susan Shin-Jung
Lin, Chin-Fu
Lu, Po-Liang
Wu, Jiunn-Jong
Ko, Wen-Chien
Lee, Wen-Sen
Hsueh, Po-Ren
Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
title Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
title_full Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
title_fullStr Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
title_full_unstemmed Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
title_short Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
title_sort susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from surveillance of multicenter antimicrobial resistance in taiwan (smart)
topic Clinical Trial Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421902/
https://www.ncbi.nlm.nih.gov/pubmed/30936726
http://dx.doi.org/10.2147/IDR.S194482
work_keys_str_mv AT laichihcheng susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT chenyingsheng susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT leenanyao susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT tanghungjen susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT leesusanshinjung susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT linchinfu susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT lupoliang susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT wujiunnjong susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT kowenchien susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT leewensen susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart
AT hsuehporen susceptibilityratesofclinicallyimportantbacteriacollectedfromintensivecareunitsagainstcolistincarbapenemsandothercomparativeagentsresultsfromsurveillanceofmulticenterantimicrobialresistanceintaiwansmart